Pasithea Therapeutics Corp.
KTTAW
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
9/100
Solvency Score
50/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Dr. Tiago Reis Marques M.D., Ph.D.
CEO
4
Employees
Miami Beach
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$5.6MEnterprise Value
-$5.3BPrice to Earnings
-0.12Price to Sales
0.00Price to Book
0.0001Price to Cash Flow
-0.0018Profitability
Return on Assets
-0.09%Return on Equity
-0.42%Return on Invested Capital
-0.11%Gross Margin
0.00%Operating Margin
0.00%Net Margin
0.00%Liquidity
Quick Ratio
3.84Current Ratio
3.84Cash Ratio
3.35Inventory Turnover
0.00Asset Turnover
0.00Total Liabilities
$1.7BSolvency
Debt to Assets
0.00Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
0.89Long-term Debt to Cap.
0.00Altman Z-Score
-5.54Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.